↓ Skip to main content

Analytical performance of a PCR assay for the detection of KRAS mutations (codons 12/13 and 61) in formalin-fixed paraffin-embedded tissue samples of colorectal carcinoma

Overview of attention for article published in Virchows Archiv, December 2011
Altmetric Badge

Citations

dimensions_citation
50 Dimensions

Readers on

mendeley
44 Mendeley
citeulike
1 CiteULike
Title
Analytical performance of a PCR assay for the detection of KRAS mutations (codons 12/13 and 61) in formalin-fixed paraffin-embedded tissue samples of colorectal carcinoma
Published in
Virchows Archiv, December 2011
DOI 10.1007/s00428-011-1180-0
Pubmed ID
Authors

Sung Lee, Victoria H. Brophy, Jianli Cao, Margot Velez, Corey Hoeppner, Stephen Soviero, H. Jeffrey Lawrence

Abstract

KRAS mutation testing is mandatory before prescribing anti-epidermal growth factor monoclonal antibodies in the treatment of advanced colorectal cancer. We describe the performance of a TaqMelt polymerase chain reaction (PCR) assay-the cobas® KRAS Mutation Test-designed to detect 19 mutations in codons 12, 13, and 61. The limit of detection was determined using DNA blends from cell lines, plasmids, and formalin-fixed paraffin-embedded tissue specimens. Assay performance was compared to Sanger sequencing using a panel of 188 specimens. Discordant specimens were subjected to next generation pyrosequencing (454). Assay repeatability was assessed using a panel of six specimens. A >95% correct mutation call rate was obtained in all specimen types with ~5% mutant alleles at DNA inputs of 0.8-6.3 ng per PCR reaction; 100% detection rate was observed at the recommended DNA input of 50 ng. The positive percent agreement with Sanger was 97.5% (79/81) for codons 12/13 and 85.7% (6/7) for codon 61. Negative percent agreement was 94.4% (101/107) for codon 12/13 and 99.4% (180/181) for codon 61. Nine of 10 discordant specimens yielded 454 results consistent with the cobas® results. With repeated testing, the assay showed a correct call rate of 100% (192/192) for all operators, instruments, reagent lots, and days tested. The cobas® test detects KRAS mutations in codons 12, 13, and 61 at a limit of detection of <5%. The PCR assay was more sensitive and specific than Sanger sequencing, and performance was highly reproducible. Test performance was not influenced by various endogenous interfering substances or common gut microbes.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 44 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Ireland 1 2%
Unknown 43 98%

Demographic breakdown

Readers by professional status Count As %
Researcher 11 25%
Other 7 16%
Student > Bachelor 6 14%
Student > Ph. D. Student 5 11%
Student > Master 4 9%
Other 4 9%
Unknown 7 16%
Readers by discipline Count As %
Medicine and Dentistry 12 27%
Agricultural and Biological Sciences 8 18%
Biochemistry, Genetics and Molecular Biology 7 16%
Mathematics 1 2%
Arts and Humanities 1 2%
Other 5 11%
Unknown 10 23%